[
  {
    "ts": null,
    "headline": "Market Sell-Off: 2 Stocks Down 17% and 36% This Year to Buy and Hold",
    "summary": "With that in mind, let's consider two stocks down 17% and 36%, respectively, this year that are worth investing in right now: Regeneron Pharmaceuticals (NASDAQ: REGN) and Moderna (NASDAQ: MRNA).  Moderna made a name for itself by quickly developing and marketing an effective COVID-19 vaccine when the world needed it most.  Moderna's revenue declined substantially while it returned to being unprofitable.",
    "url": "https://finnhub.io/api/news?id=4291f37f481bf2297e30148510041b5af3574e8980fdd16b40ce2bea1905a6b1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745674200,
      "headline": "Market Sell-Off: 2 Stocks Down 17% and 36% This Year to Buy and Hold",
      "id": 134104743,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "With that in mind, let's consider two stocks down 17% and 36%, respectively, this year that are worth investing in right now: Regeneron Pharmaceuticals (NASDAQ: REGN) and Moderna (NASDAQ: MRNA).  Moderna made a name for itself by quickly developing and marketing an effective COVID-19 vaccine when the world needed it most.  Moderna's revenue declined substantially while it returned to being unprofitable.",
      "url": "https://finnhub.io/api/news?id=4291f37f481bf2297e30148510041b5af3574e8980fdd16b40ce2bea1905a6b1"
    }
  }
]